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Abstract
The usefulness of detecting circulating non-structural protein 1
(NS1) IgM antibodies for diagnosing acute dengue virus infection
was evaluated during an outbreak investigation along with other
routinely used laboratory diagnostic methods. For the ﬁrst time,
the samples were also tested for NS1 antigen detection. NS1
IgM antibody detects all the serum samples that were positive
for NS1 antigen detection within ﬁrst 5 days of infection. The
sensitivity of the NS1 IgM ELISA was higher when compared
with RT-PCR and therefore, it could be used for early diagnosis.
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Introduction
Dengue is an endemic arboviral disease and 2.5 billion people
are at risk in 100 tropical and subtropical regions of the
world (WHO). Infection by any one of the four serotypes of
dengue virus (DENV-1 to DENV-4) could cause multiple
spectra of disease including dengue fever, dengue shock syn-
drome (DSS) and dengue haemorrhagic fever (DHF). Infection
by one serotype induces lifelong immunity but provides only
a short and transient protection against further infection by
other serotypes [1]. Most dengue infections are asymptom-
atic in nature or cause mild febrile illness, which cannot be
differentiated from other infections like malaria, leptospirosis,
typhoid, typhus and Chikungunya [2]. Severe form of dengue
DHF/DSS causes mortality and morbidity; it needs to be iden-
tiﬁed earlier and supportive measures have to be taken as
early as possible to restrict the consequences. Dengue diag-
nosis can be performed by a variety of methods but no single
technique that detects both the acute and convalescent stages
is available. Early detection of dengue virus is not only neces-
sary in the context of minimizing disease burden but also for
controlling disease spread [3]. Among various methods avail-
able for early detection, RT-PCR and non-structural protein
1 (NS1) antigen detection were widely used [4].
The NS1 of DENV is a highly conserved glycoprotein and
is produced in both a membrane-associated form and in
secreted forms [5]. NS1 is secreted during the early stage
from infected mammalian cells and stimulates a strong
humoral response. It was also shown to be produced at high
concentration during primary and secondary dengue infection
until 9 days from the onset of illness [6]. As most diagnostic
evaluations are based on detecting NS1 antigen in patient
serum, we try to evaluate the IgM immune response against
NS1 antigen (expressed in Escherichia coli as a soluble pro-
tein; S. Gowri Sankar, K. J. Dhananjeyan, R. Paramasivan, V.
Thenmozhi, B. K. Tyagi and S. J. Vennison, unpublished data)
and also its application in dengue diagnosis along with rou-
tinely used methods during an outbreak investigation in India.
Serum samples were collected during an outbreak investi-
gation from four districts in the state of Tamil Nadu, India.
The samples were processed and tested at the Centre for
Research in Medical Entomology (CRME), Indian Council of
Medical Research, Madurai which is a WHO collaborating
centre for dengue investigation. A total of 166 samples were
collected from suspected cases and out of them 69 were
from men and 97 were from women. Patients’ histories were
recorded and the samples were divided according to days
after onset of illness. Collected samples were brought to
CRME, ICMR and stored at )80C for RNA extraction and
)20C for NS1 and serological assay. RNA was extracted
from 100 ll of serum sample using QIAamp Viral RNA Mini
kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions. Detection of dengue virus was per-
formed by RT-PCR according to the method described
earlier [7]. Dengue IgM antibodies in 166 suspected serum
samples were determined using Dengue-IgM capture ELISA
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kit (MAC-ELISA; NIV-Pune, India). Detection of IgM antibod-
ies against NS1 protein (NS1-IgM ELISA) was performed [8]
along with NS1 antigen detection [9].
The samples were divided into two groups, i.e. acute sam-
ples and convalescent samples according to the number of
days after the onset of illness. Acute samples contained sus-
pected cases from day 0 (D0) to day 5 (D5), whereas the con-
valescent group contained samples collected after 5 days. As
RT-PCR and NS1 antigen detection are currently used for
diagnosing acute dengue virus infection all three tests (RT-
PCR, NS1 antigen detection and NS1 IgM detection) were car-
ried out on acute samples (within 5 days). Of the 166 tested
samples, NS1 antibody was detected in 19 samples indicating
the higher level of sensitivity of the test. The sensitivity was as
equal to NS1 antigen detection as all the 19 samples that were
positive on the test were detected by NS1 antigen detection.
The sensitivity of detection of NS1 antigen and or IgM was
higher when compared with RT-PCR, which was widely used
to diagnose dengue during acute stages. Within acute samples
(D0–D5), RT-PCR detected 14 dengue cases whereas NS1
IgM ELISA detected 19 cases including all the 14 RT-PCR
positive samples and another ﬁve samples that were not
detected by RT-PCR. The sensitivity of RT-PCR in the study
was low when compared with NS1 IgM ELISA. There is a sig-
niﬁcant difference in efﬁciency of RT-PCR and NS1 ELISA in
diagnosing acute dengue cases (P >0.05) (as we have not car-
ried out experiments in deﬁned dengue cases, our evaluation,
sensitivity and report are given in number of positives and
not in percentage). One of the limitations of the study was
that no paired sera were used and hence the test did not dis-
tinguish between primary and secondary infection. Positive
detection of NS1 IgM antibody from the date of onset of
illness illustrates the sensitivity of the test (Table 1). When
RT-PCR was combined with MAC-ELISA the overall number
of positive samples was increased to 28. When NS1 IgM
ELISA results were combined with MAC-ELISA it gave 32
positive dengue samples. The difference was the result of the
sensitivity of NS1 IgM ELISA during acute stages of infection
over RT-PCR. Individual reaction patterns of all positive den-
gue samples are given for comparison in Table 2. Our data
correlate well with results reported earlier [8,10,11]. Though
RT-PCR may not be sensitive in diagnosing acute dengue
cases, it is the only available method for serotyping dengue
TABLE 1. Sensitivities of NIV IgM ELISA (MAC-ELISA), RT-PCR, non-structural protein 1 (NS1) antigen detection and NS1
IgM ELISA in the diagnosis of dengue infection related to number of days after onset of illness (n = 166)
Days after
onset of illness
No. of
samples
Number of positive samples
RT-PCR
MAC
ELISA
NS1 Ag
detection
NS1 IgM
ELISA
RT-PCR +
MAC ELISA
NS1 Ag detection +
MAC ELISA
NS1 IgM +
MAC ELISA
0a 5 2 0 4 4 2 4 4
1 10 3 0 3 3 3 3 3
2 36 2 2 3 3 2 3 3
3 32 4 4 5 5 4 5 5
4 20 3 4 4 4 4 4 4
5 20 0 2 0 0 2 2 2
6 17 ND 3 ND ND 3 3 3
7 12 ND 2 ND ND 2 2 2
> 7 14 ND 6 ND ND 6 6 6
Total 166 14 23 19 19 28 32 32
ND, not done.
a0 day is deﬁned as serum sample taken within ﬁrst 24 h from the onset of illness.
TABLE 2. Individual reaction pattern of all positive dengue
samples
Sample
no.
Sample
no.
RT-
PCR
MAC-
ELISA
NS1-antigen
detection
NS1-IgM
ELISA
Sampling
timea
1 A032 + + + + 2
2 A045 + ) + + 1
3 A069 + ) + + 0
4 A072 ) + + + 3
5 B021 ND + ND ND 7
6 B036 ) ) + + 0
7 B049 + + + + 3
8 B086 ND + ND ND 6
9 C009 ND + ND ND >7
10 C010 + ) + + 2
11 C029 ND + ND ND 6
12 C058 ND + ND ND >7
13 C065 ND + ND ND 6
14 C079 + ) + + 0
15 AB023 + ) + + 3
16 AB034 ND + ND ND >7
17 AB049 ) + + + 2
18 AB086 + + + + 3
19 BC006 ) ) + + 0
20 BC016 ND + ND ND 7
21 BC050 ND + ND ND >7
22 BA031 + ) + + 1
23 BA046 + + + + 4
24 BA052 + + + + 3
25 BA062 + ) + + 1
26 BA079 ND + ND ND >7
27 BA096 ND + ND ND >7
28 BA098 ) + + + 4
29 BA109 ) + ) ) 5
30 BD003 + + + + 4
31 BD025 ) + ) ) 5
32 BD039 + + + + 4
ND, not done.
aSampling time = number of days after onset of illness.
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infections [12]. Our ﬁndings are signiﬁcant in two ways. To
our knowledge this is the ﬁrst report that describes the com-
prehensive use of NS1 IgM detection for acute dengue virus
diagnosis along with an NS1 antigen detection test. Further-
more, all the tests were carried out during an outbreak inves-
tigation, which highlights the application of NS1 IgM detection
in terms of usefulness and applicability in diagnosis.
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